Eye Drops Visimitin

Vizomitin - eye drops Skulacheva - a medical product that contributes to the normalization of the tear-producing function of the conjunctiva. To date, eye drops Visomitin are the only remedy that not only eliminates symptoms, but also affects the causes of a number of ophthalmic diseases.

Composition and form of the drop Vizomitin

The main active component of the drug is plastoquinonyl decyltriphenylphosphonium bromide, which has an antioxidant effect. In addition, this substance normalizes the production of natural tears and increases the stability of tear film. Also, the medicine contains auxiliary components:

Vizomitin drops are a clear, almost colorless liquid in a 5 ml polyethylene bottle equipped with a dropper.

The pharmaceutical agent Visomitin is released only on the basis of the prescription. Shelf life of the drug is 1 year, and the printed bottle can be stored for no more than one month. Storage of eye drops Visomitin is possible at a temperature of + 2 ... + 80.

Indications and contraindications for the use of Visomitin

Proceeding from the fact that the main signs of eye aging are age-related disorders of the lacrimal gland, innovative drops of Vizomitin were developed on the basis of a fundamental difference from the effect of other drugs used in the "dry eye" syndrome: they stop degenerative processes.

Drops of Skulacheva Visomitin are shown in the following eye diseases and conditions:

Drops are also successfully used in complex therapy for inflammatory diseases of the eyes.

Contraindications to the use of drops Visomitin are:

Instructions for the use of eye drops Visimitin

The medicine is digested three times a day for 1-2 drops in each eye conjunctival sac. The duration of the treatment course is determined by the ophthalmologist, taking into account the severity of the symptoms and the severity of the course of the disease.

If Visimitin is used in combination with other eye drops, it is necessary to maintain a time interval of at least 5 minutes between instillation of different medications.

Attention! As a result of clinical trials, it was found that visomitin can cause short-term disruption of pupillary accommodation, and therefore it is recommended to refrain from driving while taking therapy with this medication.

It should be especially emphasized that there are no analogues of eye drops Visomitin. An ophthalmic preparation developed at the Russian Academy of Sciences by a laboratory under the guidance of V. Skulachev has a truly unique property: it is a keraprotector that restores mitochondria in the eye cells. The cost of the medicine is from 12 to 18 cu, but its restorative effect on the organ of vision is incomparable with that of other eye drops, which cost 2-3 times cheaper. Among them:

Patients already using in the treatment of eye diseases Visomitin, respond positively to the action of the drug and show a desire to apply it in the future. High efficiency of the action of Vizomitin drops is also noted by ophthalmologists.